The use of genomic information in healthcare is increasing rapidly, and the inclusion of single nucleotide polymorphisms (SNP) testing to provide a polygenic risk score can be utilized in breast cancer risk assessment to enhance the accuracy of risk assessment and provide a more personalized estimate of breast cancer risk. The purpose of this research is to understand women’s experience of receiving breast cancer risks based on SNP testing results.
National Health & Medical Research Council
Ms Mary-Anne Young
Ms Maatje Scheepers-Joynt
Email: [email protected]
Publications & presentations
Young MA, Forrest L, Rasmussen V, James P, Mitchell G, Sawyer SD, Reeve K, Hallowell N. Making sense of SNPs: Patients’ understanding and experiences of SNP profiling for hereditary breast cancer. Submitted to GIM Nov 2015